Génome Québec is proud to announce funding for a new research project intended to accelerate the discovery of antiviral COVID-19 medications.
This project spearheaded by professors Michael Tyers (IRIC/Université de Montréal), Yoshua Bengio (Mila/Université de Montréal) and Anne Marinier (IRIC/Université de Montréal), the $1 million project combines genomics, artificial intelligence and medicinal chemistry to discover new inhibitors of the SARS-CoV-2 virus that causes COVID-19.
By consolidating world-renowned expertise in genomics, artificial intelligence and medicinal chemistry, this project is placing Québec and Canada at the cutting edge of research in precision medicine.